Could Machine Learning models serve to predict depression in early pregnancy in racial/ethnic minority women?

Madri­gal Phar­ma­ceu­ti­cals kicked off the reg­u­la­to­ry re­view process for its ex­per­i­men­tal NASH treat­ment as it pur­sues the first FDA ap­proval to treat the de­bil­i­tat­ing and

When Tony Wood be­came GSK’s top sci­en­tist in mid-2022, the British phar­ma was wag­ing bat­tle. GSK was fight­ing Zan­tac-re­lat­ed lit­i­ga­tion in court while strug­gling to